Target Price | $58.20 |
Price | $45.46 |
Potential |
28.02%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Amphastar Pharmaceuticals Inc 2025 .
The average Amphastar Pharmaceuticals Inc target price is $58.20.
This is
28.02%
register free of charge
$66.00
45.18%
register free of charge
$55.00
20.99%
register free of charge
|
|
A rating was issued by 6 analysts: 4 Analysts recommend Amphastar Pharmaceuticals Inc to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Amphastar Pharmaceuticals Inc stock has an average upside potential 2025 of
28.02%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 644.40 | 737.66 |
29.14% | 14.47% | |
EBITDA Margin | 37.47% | 40.56% |
37.24% | 8.25% | |
Net Margin | 19.52% | 23.16% |
15.71% | 18.67% |
6 Analysts have issued a sales forecast Amphastar Pharmaceuticals Inc 2024 . The average Amphastar Pharmaceuticals Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Amphastar Pharmaceuticals Inc EBITDA forecast 2024. The average Amphastar Pharmaceuticals Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Amphastar Pharmaceuticals Inc Analysts have issued a net profit forecast 2024. The average Amphastar Pharmaceuticals Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 2.60 | 3.53 |
49.43% | 35.77% | |
P/E | 12.87 | |
EV/Sales | 3.47 |
4 Analysts have issued a Amphastar Pharmaceuticals Inc forecast for earnings per share. The average Amphastar Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Amphastar Pharmaceuticals Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Amphastar Pharmaceuticals Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.